Interim Management Statement

Dechra Pharmaceuticals PLC
17 October 2007



Issued by Citigate Dewe Rogerson Ltd, Birmingham
Date: Wednesday, 17 October 2007


                         Dechra(R) Pharmaceuticals PLC
                          Interim Management Statement



Dechra Pharmaceuticals PLC ('Dechra' or the 'Group'), which holds its Annual
General Meeting today at 10.00 am, publishes its first Interim Management
Statement as required by the UK Listing Authority Disclosure and Transparency
Rules.


The Group has started the financial year in line with management expectations;
there have been no significant changes in its financial position or performance
since the publication of the Annual Report in respect of the year ended 30 June
2007 and the financial position of the Group remains strong.


The Pharmaceuticals Division has continued its strong growth with revenue for
the first quarter of the financial year ahead of the same period last year.  The
Group's US operation is achieving encouraging revenues from the Pharmaderm
products acquired in May and is now trading profitably.


The Services Division continues to take advantage of strong market conditions,
with market share at National Veterinary Services remaining above 44%.


There have been no material events or transactions between 1 July 2007 and the
date of this announcement.


The Board remains confident that the Group will continue to make good strategic
progress in line with management expectations throughout the remainder of the
financial year.




Enquiries:
Ian Page, Chief Executive                               Fiona Tooley, Director
Simon Evans, Group Finance Director                     Keith Gabriel, Senior Account Manager
Dechra Pharmaceuticals PLC                              Citigate Dewe Rogerson
Tel: [phone]                                       Tel: [phone]
Mobile: [phone] (IP) or 07775 642220 (SE)          Mobile: [phone] (FMT) or 07770 788624 (KG)
www.dechra.com
[e-mail]



Trade Marks appear throughout this release in italics.  Dechra and the Dechra 
'D' logo are registered Trade Marks of Dechra Pharmaceuticals PLC.


                      This information is provided by RNS
            The company news service from the London Stock Exchange                  LID